Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadim Mahmud

Showing results (21-30 of 239) with videos related to

Pageof 24
Sort By:
Annals of Hepatology|June 1, 2020
The imperative for an updated cirrhosis surgical risk scoreNatalie Zhen Wong, Nadim Mahmud
Hepatology (Baltimore, Md.)|April 21, 2020
ReplyNadim Mahmud, Sumeet K Asrani
Hepatology Communications|March 30, 2023
Assessing the risk of surgery in patients with cirrhosisMelissa G Kaltenbach, Nadim Mahmud
Journal of Clinical and Experimental Hepatology|November 17, 2023
Statins in Cirrhosis: Hope or Hype?Lauren R Shaffer, Nadim Mahmud
Mabs|February 13, 2010
Antibody immunosuppressive therapy in solid-organ transplant: Part INadim Mahmud, Dusko Klipa, Nasimul Ahsan
Crohn'S & Colitis 360|July 18, 2025
Long-Term Effectiveness and Safety of Tofacitinib in a Nationwide Veterans Affairs Cohort of Ulcerative Colitis PatientsNabeel Khan, Ramaswamy Sundararajan, Nadim Mahmud
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|May 25, 2010
A text message-based intervention to bridge the healthcare communication gap in the rural developing worldNadim Mahmud, Joce Rodriguez, Josh Nesbit
The American Journal of Gastroenterology|May 5, 2026
Guidelines in Practice: Preoperative Risk Assessment and Management in Patients with CirrhosisDilara Hatipoglu, Akshatha Kiran, Nadim Mahmud
Hepatology Communications|December 1, 2025
Five essential features for adoption of clinical risk prediction tools: Insights from the VOCAL-Penn scoreKinza Khan, Mackenzie Bolas, Nadim Mahmud
Mabs|October 16, 2010
Antibody immunosuppressive therapy in solid organ transplant: Part IIDusko Klipa, Nadim Mahmud, Nasimul Ahsan
Pageof 24

Showing results (21-30 of 239) with videos related to

Sort By:
Pageof 24
Annals of Hepatology|June 1, 2020
The imperative for an updated cirrhosis surgical risk scoreNatalie Zhen Wong, Nadim Mahmud
Hepatology (Baltimore, Md.)|April 21, 2020
ReplyNadim Mahmud, Sumeet K Asrani
Hepatology Communications|March 30, 2023
Assessing the risk of surgery in patients with cirrhosisMelissa G Kaltenbach, Nadim Mahmud
Journal of Clinical and Experimental Hepatology|November 17, 2023
Statins in Cirrhosis: Hope or Hype?Lauren R Shaffer, Nadim Mahmud
Mabs|February 13, 2010
Antibody immunosuppressive therapy in solid-organ transplant: Part INadim Mahmud, Dusko Klipa, Nasimul Ahsan
Crohn'S & Colitis 360|July 18, 2025
Long-Term Effectiveness and Safety of Tofacitinib in a Nationwide Veterans Affairs Cohort of Ulcerative Colitis PatientsNabeel Khan, Ramaswamy Sundararajan, Nadim Mahmud
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|May 25, 2010
A text message-based intervention to bridge the healthcare communication gap in the rural developing worldNadim Mahmud, Joce Rodriguez, Josh Nesbit
The American Journal of Gastroenterology|May 5, 2026
Guidelines in Practice: Preoperative Risk Assessment and Management in Patients with CirrhosisDilara Hatipoglu, Akshatha Kiran, Nadim Mahmud
Hepatology Communications|December 1, 2025
Five essential features for adoption of clinical risk prediction tools: Insights from the VOCAL-Penn scoreKinza Khan, Mackenzie Bolas, Nadim Mahmud
Mabs|October 16, 2010
Antibody immunosuppressive therapy in solid organ transplant: Part IIDusko Klipa, Nadim Mahmud, Nasimul Ahsan
Pageof 24